RaySearch Laboratories has received 510(k) approval for the extended version of its RayStation 4.0 treatment planning system, which features tools for optimisation of proton treatments using the pencil beam scanning technique.
RaySearch can now market the new version of RayStation 4.0 in the US with the 510(k) approval. In December 2013, the extended version of RayStation 4.0 treatment planning system received CE Mark approval.
The pencil beam scanning technique enables intensity modulated proton therapy, which allows clinicians to target a cancerous tumour by controlling both the strength and spatial distribution with millimetre-precision.
RaySearch claims that RayStation’s proton module features all the tools required for PBS such as multiple field optimisation, single field uniform dose and distal edge tracking techniques.
RaySearch CEO Johan Lof said that the company has won several orders and been the most successful supplier of solutions for proton treatment planning over the last year.
"Our position on the US market becomes even stronger now that we have market clearance for all relevant techniques for proton therapy," Lof said.
RayStation has been built using the latest software architecture and integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system, as well as a graphical user interface.
It combines features such as multi-criteria optimisation tools with full support for 4D adaptive radiation therapy.
The new treatment planning system includes functionality such as RaySearch’s algorithms for intensity-modulated radiation therapy and volumetric modulated arc therapy optimisation and highly accurate dose engines for photon, electron and proton therapy.
Image: RaySearch Laboratories’ RayStation treatment planning system. Photo: courtesy of RaySearch Laboratories.